Sitagliptin for the Treatment of Grade 3-4 and Refractory Acute Graft-versus-host Disease
Clinical trial NCT04448587 · UNKNOWN
Trial details
- NCT number
- NCT04448587
- Sponsor
- Rabin Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2021-12-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.